PS128
LIVE

Serial Number

99301747

Owner

Bened Biomedical Co., Ltd.

Attorney

VIVEK VAIDYA

First Use Date

Aug 21, 2015

Filing Date

Jul 24, 2025

Add to watchlist:

No watchlists yet
View on USPTO

PS128 Trademark

Serial Number: 99301747

PS128 is a trademark filed by Bened Biomedical Co., Ltd. on July 24, 2025. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Bened Biomedical Co., Ltd. (2 trademarks)

8F., No. 508, Sec. 7,

Entity Type: 98

Trademark Details

Filing Date

July 24, 2025

Registration Date

Not Registered

First Use Anywhere

August 21, 2015

First Use in Commerce

April 30, 2019

Goods & Services

Pharmaceutical agents affecting peripheral nervous system made in whole or substantial part of Lactobacillus plantarum PS128; pharmaceutical preparations acting on the central nervous system made in whole or substantial part of Lactobacillus plantarum PS128; medicated candies made in whole or substantial part of Lactobacillus plantarum PS128; dietetic foods adapted for medical use made in whole or substantial part of Lactobacillus plantarum PS128; biological preparations for veterinary purposes made in whole or substantial part of Lactobacillus plantarum PS128 for the treatment of separation anxiety, aggression, compulsive disorder, excessive barking, yowl and stabilize emotional status; Preparations of microorganisms for medical or veterinary use made in whole or substantial part of Lactobacillus plantarum PS128 for the treatment of autism spectrum disorder, Parkinson's disease, Alzheimer's disease, depressive disorder, Tourette syndrome, visceral hypersensitivity, constipation, insomnia, stress, separation anxiety, aggression, compulsive disorder, excessive barking, yowl and stabilize emotional status; nutraceutical preparations for therapeutic or medical purposes made in whole or substantial part of Lactobacillus plantarum PS128 for the treatment of autism spectrum disorder, Parkinson's disease, Alzheimer's disease, depressive disorder, Tourette syndrome, visceral hypersensitivity, constipation, insomnia, and stress; milk ferments for pharmaceutical purposes made in whole or substantial part of Lactobacillus plantarum PS128; biological preparations for medical purposes made in whole or substantial part of Lactobacillus plantarum PS128 for the treatment of autism spectrum disorder, Parkinson's disease, Alzheimer's disease, depressive disorder, Tourette syndrome, visceral hypersensitivity, constipation, insomnia, and stress; powdered whey proteins being nutritional supplements made in whole or substantial part of Lactobacillus plantarum PS128.

Filing History

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
May 12, 2026 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
May 12, 2026 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 13, 2026 GNRN
NON-FINAL ACTION E-MAILED
Feb 13, 2026 GNRT
NON-FINAL ACTION WRITTEN
Feb 13, 2026 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 16, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 16, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 16, 2026 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 7, 2026 GNRN
NON-FINAL ACTION E-MAILED
Jan 7, 2026 GNRT
NON-FINAL ACTION WRITTEN
Jan 7, 2026 CNRT
ASSIGNED TO EXAMINER
Dec 10, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 2, 2025 NWOS
APPLICATION FILING RECEIPT MAILED
Jul 24, 2025 MAFR
NEW APPLICATION ENTERED
Jul 24, 2025 NWAP